Until recently, a central assumption in neuroscience had been that new neurons do not arise in the adult mammalian brain. This idea prevailed in spite of reports, published in prominent journals, that showed that new neurons could arise in specialized areas of the brain ([@b2-cia-2-605]; [@b3-cia-2-605], [@b4-cia-2-605]; [@b47-cia-2-605]; [@b46-cia-2-605]). In the last few years, however, this belief has been challenged by numerous studies that demonstrated that certain areas of the brain retain pluripotent precursors with the capacity of self-renew and differentiation into new neural lineages in adult mammals such as rodents ([@b11-cia-2-605]; [@b53-cia-2-605]; [@b49-cia-2-605]; [@b66-cia-2-605]), non-human primates ([@b72-cia-2-605]), and humans ([@b32-cia-2-605]; [@b54-cia-2-605]; [@b65-cia-2-605]). In rodents, it was shown that undifferentiated neural stem/progenitor cells (NSCs) are concentrated in the subventricular zone (SVZ) of the lateral ventricle wall ([@b66-cia-2-605]) and the subgranular zone (SGZ) of the dentate gyrus of the hippocampus ([@b35-cia-2-605]). Cells born in the rodent SVZ during adult life travel anteriorly through the rostral migratory stream into the olfactory bulb (OB), where they differentiate into interneurons ([@b5-cia-2-605]). Cells born in the SGZ of the dentate gyrus migrate a short distance to integrate in the granular layer ([@b35-cia-2-605]). The SGZ of the dentate gyrus in young adult rats contains about 9,400 dividing cells proliferating with a cell cycle time of 25 hours, which would generate 9,000 new cells each day, or more than 250,000 per month ([@b20-cia-2-605]) and a high proportion of them differentiate into neurons ([@b39-cia-2-605]; [@b93-cia-2-605]). However, only about half of these newly generated neurons will survive after the first few weeks ([@b21-cia-2-605]; [@b29-cia-2-605]). Those that survive seem to integrate into preexisting hippocampal circuits and may permanently replace granule cells born during development ([@b29-cia-2-605]). Remarkably, production overweighs loss of proliferating progenitors in the rat hippocampus such that neuronal cell numbers increase continuously until middle-age ([@b12-cia-2-605]).

That NSCs also exist in adult primate and human brain has now been well established ([@b54-cia-2-605]; [@b72-cia-2-605]; [@b13-cia-2-605]; [@b16-cia-2-605]; [@b14-cia-2-605]) for the subependymal zone ([@b76-cia-2-605]), for the hippocampus ([@b32-cia-2-605]; [@b76-cia-2-605]) and very recently for the human olfactory bulb ([@b14-cia-2-605]; [@b78-cia-2-605]; [@b27-cia-2-605]). The dentate gyrus and the hilus in cornus ammonis 4 (CA4) region of the human hippocampus are, however, the most active areas of NSC proliferation in adult non-human primates ([@b52-cia-2-605]) and humans ([@b32-cia-2-605]). NSCs are maintained in specialized microenvironments in these brain regions ([@b7-cia-2-605]), in which they may undergo symmetrical division at a very low rate maintaining their pluripotency, or alternatively undergo asymmetric division to differentiate into neuronal precursors (NPs) ([@b70-cia-2-605]; [@b86-cia-2-605]).

Together with the refutation of the paradigm of 'brain constancy', a 'neurocentric' view of the brain is also being reconsidered. In addition to having an essential role in neural function, which can be thought of as mediated by neuronalglial systems as a whole ([@b59-cia-2-605]), the studies of Alvarez-Buylla and coworkers ([@b63-cia-2-605]; [@b6-cia-2-605]) and other groups ([@b8-cia-2-605]) demonstrated that astrocytes in the SVZ and SGZ are NSCs in mammals and that radial glia may function as progenitors for the majority of neurons in mammalian central nervous system (CNS).

The neurogenicity of SVZ and SGZ NSCs in the young adult mammalian brain is restricted by signals from their local environment, as demonstrated with transplantation experiments that showed that SVZ cells loose their neurogenic potential if placed into non-spontaneously neurogenic regions of the brain ([@b7-cia-2-605]). Conversely, after heterotopic transplantation into the hippocampus, NSCs isolated from the adult spinal cord can integrate in the granular cell layer and differentiate into cells characteristic of this region, whereas engraftment into other hippocampal regions resulted in the differentiation of cells with astroglial and oligodendroglial phenotypes. These observations suggested that multipotent adult progenitor cells from a non-neurogenic region are not lineage-restricted to their developmental origin but can generate region-specific neurons in vivo when exposed to the appropriate environmental cues ([@b82-cia-2-605]). Not surprisingly, developmental signal molecules and morphogens such as Notch ([@b9-cia-2-605]; [@b36-cia-2-605]), bone morphogenetic proteins, Noggin and sonic hedgehog ([@b74-cia-2-605]), have been implicated in the maintenance of adult neurogenic microenvironments ([@b60-cia-2-605]) containing glial and endothelial cells ([@b81-cia-2-605]).

The function of adult neurogenesis is still not known. In 2001, however, [@b83-cia-2-605] showed that performance of a hippocampus-dependent learning task was dependent on the presence of replicating NSCs, suggesting that neurogenesis in the adult hippocampus has a role in learning memory ([@b83-cia-2-605]), although not all forms of hippocampal-dependent memory are associated with neurogenesis ([@b84-cia-2-605]; [@b68-cia-2-605]). [@b30-cia-2-605] demonstrated that activity and neurogenesis are coupled, a process that would implement a form of network plasticity conceptually analogous to plasticity at the synaptic level, but occurring at the cellular network level. Indeed, organismal-level stimuli that entail an increase in neuronal activity such as learning ([@b37-cia-2-605]; [@b57-cia-2-605]), exposure to environmental enrichment ([@b92-cia-2-605]; [@b18-cia-2-605]), exposure to hippocampal-dependent learning tasks ([@b29-cia-2-605]; [@b57-cia-2-605]), and voluntary running ([@b92-cia-2-605]; [@b18-cia-2-605]) have been shown to stimulate neurogenesis and enhance the survival of new neurons in the adult mammalian hippocampus, which in the case of running required vascular endothelial growth factor (VEGF) systemically ([@b33-cia-2-605]; [@b22-cia-2-605]). Although neither of these behavioral interventions increased adult neurogenesis in the SVZ/OB ([@b18-cia-2-605]), proliferation in these areas was influenced by olfactory sensory enrichment. The observed increase in newborn neurons was concomitant with improved olfactory memory in enriched animals ([@b75-cia-2-605]). A pivotal role for adult neurogenesis in plasticity at the organismal level was indicated by recent studies showing that new granular cells formed in the epileptic rat dentate gyrus, but not in other conditions of neurogenesis stimulation, exhibited functional connectivity consistent with reduced excitability ([@b42-cia-2-605]). Taken together, these observations strongly suggest that activity of specific networks stimulates local neurogenesis and the survival of differentiated progenitors, which in turn contribute to enhanced function ([@b75-cia-2-605]), or act to mitigate dysfunction ([@b42-cia-2-605]).

Stem cells in neurogenic areas respond to other types of injury. Acute insults, such as focal ischemia induced by middle cerebral artery occlusion in rat, stimulate the proliferation of NSCs after extensive damage has occurred in the striatum and parietal cortex ([@b10-cia-2-605]). Traumatic brain injury has also been reported to induce neurogenesis ([@b26-cia-2-605]), and this response can persist in the long term in the adult brain ([@b25-cia-2-605]). The activation of neurogenic processes as a response to chronic damage is much less well documented, although some ([@b28-cia-2-605]; [@b43-cia-2-605]; [@b43-cia-2-605]) but not all ([@b40-cia-2-605]; [@b40-cia-2-605]; [@b55-cia-2-605]; [@b31-cia-2-605]) studies have supported the hypothesis that slow neurodegenerative damage may also induce NSC proliferation. The evidence for de novo neurogenesis induced by chronic injury, however, is far from being definitive.

Although neurogenesis continues throughout life, its rate declines with increasing age in rodents ([@b80-cia-2-605]; [@b53-cia-2-605]; [@b48-cia-2-605]) and non-human primates ([@b37-cia-2-605]). In aged rats, the proliferation rate of NSCs in the SGZ of the dentate gyrus is reduced by 80% ([@b45-cia-2-605]). The bulk of age-related decreases in SGZ neurogenesis takes place between 3 and 12 months of age ([@b53-cia-2-605]). In addition, the proportion of these NSCs that survive to become mature neuronal cells is reduced to half of that of young animals ([@b88-cia-2-605]). In contrast, the SVZ, the other prominently neurogenic area in rodent brain, suffers no significant ([@b53-cia-2-605]) or less severe ([@b45-cia-2-605]; [@b64-cia-2-605]) decreases in the rate of NSC proliferation.

The age-associated reduction in adult neurogenesis may be due to an intrinsic decline in NSC responsiveness to stimulating environmental cues, to a decrease in or disappearance of these environmental cues, or to the appearance or accumulation of inhibitory factors. Supporting a role for environmental cues in the age-associated decline in neurogenesis, it was shown that exogenous addition of growth factors such as insulin-like growth factor I (IGF-I) ([@b58-cia-2-605]), epidermal growth factor (EGF) and fibroblast growth factor (FGF-2) ([@b45-cia-2-605]) or a reduction of corticosteroid levels by adrenalectomy ([@b19-cia-2-605]) can, at least partially, negate the effects of age in the rate of NSC proliferation. Consistent with these observations, repeated social stress significantly decreased the rate of NSC proliferation in mice ([@b69-cia-2-605]), while environmental enrichment ([@b48-cia-2-605]) and voluntary exercise ([@b92-cia-2-605]) significantly reversed age-related decreases in NSC proliferation. Newly born neurons in aged mice were morphologically indistinguishable from those generated in young animals ([@b92-cia-2-605]), and their increased numbers were accompanied by substantial and sustained behavioral improvements ([@b48-cia-2-605]). The observed increase in adult born neurons in older animals were at the expense of newly generated astrocytes, arguing that the effects of environmental enrichment affect the fate choice of proliferating multipotent progenitors or alternatively, specifically promote survival of newly born neurons. Environmental conditions may therefore have a crucial role in the modulation of neurogenesis during aging in rodents since like in young rodents experience, the stimulation of neurogenesis and improved functional outcomes may be causally linked in aged brains as well.

Age-associated memory deficits are broadly similar to those induced by damage to the hippocampus, which is one of several limbic structures implicated in the pathophysiology of mood disorders. It was recently shown that stress ([@b17-cia-2-605]) and depression ([@b61-cia-2-605]; [@b87-cia-2-605]; [@b34-cia-2-605]) lead to hippocampal atrophy, while chronic antidepressant treatments result in an increase in hippocampal neurogenesis. Antidepressant action may require neurogenesis in mice ([@b79-cia-2-605]), although hippocampal neurogenesis was not required for the anxiolytic effects of environmental enrichment ([@b68-cia-2-605]). It has been proposed that the age-related decline in neurogenesis may underlie age-associated learning and memory declines and may contribute to pathological conditions such as Alzheimer's disease ([@b40-cia-2-605]; [@b40-cia-2-605]; [@b31-cia-2-605]). Although neurogenesis may contribute to function in the adult human CNS, the process does not suffice to preserve function during normal aging, or when injury or degenerative processes have ensued. However, that stimulation of NSC proliferation and possibly survival may be enhanced by growth factors or behavioral interventions even in older rodents ([@b15-cia-2-605]; [@b45-cia-2-605]; [@b72-cia-2-605]) suggests that the endogenous neurogenic response could be modulated exogenously. Even though the overall level of endogenous neurogenesis is decreased in all mammals examined to date, the responsiveness of NSC proliferation is retained in aged mouse brains ([@b45-cia-2-605]) and human brains ([@b32-cia-2-605]). Remarkably, and albeit the sample number precluded drawing quantitative conclusions, [@b32-cia-2-605] showed that the highest number of proliferating precursors in the granule cell layer and in the hilus of the dentate gyrus in human adults were found in subjects of middle and advanced age. How and to what extent our knowledge about neurogenic processes in rodents will ultimately translate to neurogenic processes in the adult primate brain is still unknown. In rodents, cells born in the SVZ travel anteriorly through the RMS into the OB, where they differentiate into interneurons ([@b5-cia-2-605]). This process is referred to as "chain migration" ([@b62-cia-2-605]). The RMS that continues to supply replacement interneurons to the rodent OB is weak in humans, possibly reflecting the reduced functionality of the human OB. This is consistent with a reduced functionality of olfaction, as evidenced by the substantial loss of functional olfactory receptor genes in the human genome when compared to rodents. In 2004, however, a report by [@b14-cia-2-605] described cells expressing cell cycle markers and markers for immature neurons in the human OB, suggesting that precursor proliferation may also occur, albeit at a much reduced rate, in this region of the adult human brain. The human RMS was finally demonstrated around a lateral ventricular extension reaching the OB, the ventriculo-olfactory neurogenic system (VONS) which, in contrast to the rodent brain, takes a caudal path en route from the SVZ to the olfactory cortex as a consequence of the pronounced enlargement of the frontal cortex in the human forebrain that places the rostral caudate, SVZ and frontal cortex rostral to the olfactory tubercle ([@b27-cia-2-605]). In contrast, the dentate gyrus and the hilus in CA4 region of the human hippocampus, which were detected earlier, are possibly the most active areas of progenitor proliferation in adult primates ([@b72-cia-2-605]) and humans ([@b32-cia-2-605]).

Apart from differences that likely reflect differential evolutionary paths in rodents and primates, available knowledge for neurogenesis in the two mammalian orders so far point to a fairly large degree conservation in the general regulation and in the impact of the aging in neurogenic processes.

Endogenous augmentation of trophic factor expression (such as brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and FGF-2) in brains of laboratory animals has been achieved by behavioral interventions ([@b67-cia-2-605]) such as enriched experience, voluntary exercise ([@b51-cia-2-605]) and training/learning ([@b94-cia-2-605]). Both enriched housing and training have been shown to increase synaptogenesis ([@b24-cia-2-605]) and neurogenesis ([@b92-cia-2-605]) as well. IGF-I has neuroprotective and neurogenic effects ([@b89-cia-2-605]; [@b89-cia-2-605]) and it has been shown that peripheral infusion of IGF-I can increase NSC proliferation, selectively induce neurogenesis ([@b1-cia-2-605]) and ameliorate the age-related decline in hippocampal neurogenesis in rats ([@b58-cia-2-605]). The protective effects of physical exercise were shown to be mediated by circulating IGF-I ([@b23-cia-2-605]). A thorough consideration of the challenges to the design of treatment strategies based on the simulation of endogenous neurogenesis for replacement of affected networks, mainly centered on the delivery of growth factors, can be found in the review article by [@b59-cia-2-605].

The ultimate requirement for neurogenesis to be beneficial in the adult is that it contributes to function, according to its cognitive and psychological definition ([@b50-cia-2-605]). Survival and acquisition of a neuronal phenotype by NSCs are dependent not only on network activity, but also on the existence of a complete environment capable of supporting survival, maturation and function by the production of neurotrophins and other regulators of proliferation and differentiation ([@b56-cia-2-605]; [@b71-cia-2-605]; [@b85-cia-2-605]; [@b91-cia-2-605]). When the network structures in which NSCs can integrate are compromised, as in normal aged brains or in neurodegerative conditions, increased proportions of proliferating progenitors may die. Would ongoing neurogenic processes positively contribute to enhanced function in all circumstances, or might there be a requirement for a minimal degree of integrity of network structures for neurogenesis to be beneficial? It is conceivable that the role of neurogenesis during the course of aging may be dictated by the degree of permissibility of the environment in which the process is taking place.

The discovery of neurogenesis and its role in the adult mammalian brain opened up exciting possibilities for the development of therapeutic interventions that might mitigate age-related learning and memory declines, and mood disorders. Even though the gaps in our understanding of the neurogenic process are not insignificant, it is likely that continuing investigation into the basic biology of adult NSCs will allow us to modulate cell replacement processes in the adult brain. As simple behavioral interventions can stimulate neurogenesis in rodent experimental models and possibly in humans, it is reasonable to suggest that lifestyle changes may constitute a therapeutic approach of low risk, albeit of variable efficacy, for the early prevention of age-associated or pathological cognitive decline. Behavioral interventions such as the diffusion of information required for lifestyle choices, the socialization of institutions providing access to continuing education, creative occupation, physical activity and the enjoyment of the arts may help societies increase their overall "cognitive reserve" and reduce the human, economic and social burden associated with increased numbers of cognitively impaired elderly in developed societies with high life expectancy.
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